Agency Title Period
EU Marine Microbial Biodiversity, Bioinformatics and Biotechnology (MICRO B3) 2012-2016
EU Marine Microorganisms: Cultivation Methods for improving their Biotechnological Applications (MACUMBA) 2012-2016
EU Increasing Value and Flow in the Marine Biodiscovery Pipeline (PharmaSea) 2012-2016
IRCSET Understanding the molecular mechanism through which aspirated bile triggers chronic P. aeruginosa infections in respiratory disease. 2014-2018
SFI Tida 2014 Next Generation Antibiotics:  anti-biofilm, anti-pathogenic natural bioactives from marine microorganisms. 2015-2016
DAFF Marine Institute (Beaufort) 'Marine Biodiscovery/Biotechnology 2007-2015
EU INMARE Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea 2015-2018
O'Brien Fine Foods Microbial diversity and abundance analysis in process cover brine. 2014-2016
FIRM ( Dept Ag/Marine) Use of Marine derived Antibacterial agents to combat Salmonella in Pork Products. Aug 2013-2016
SFI National Centres .  Synthesis and Solid State Pharmaceutical Centre June 2013 –2019
Eu - Madam Curie  ITN Blue Pharma Sept 2013— 2017
Teagasc Walsh Fellowship The use of marine derived antibacterial agents to combat the prevalence of Salmonella in pork products Oct 2013 - Sep 2017
FIRM ( Dept Ag/Marine) The anti-inflammatory and Microbial modulatory effects of marine derived Laminarin and  omega 3 fatty acid on inflammatory bowel disease in an expimental porcine  model 2014-2018
Irish T.S. Investigate the impact of bile aspiration on chronic respiratory desease:  Chronic infection - Bile Paradigm 2014-2016
Close X